搜尋結果
Lock in attractive real yields with this inflation-protected investment, says UBS
CNBC· 1 日前After upgrading 5-year TIPS in August to most preferred and seeing them outperform 5-year ...
The Canadian Association of Optometrists Releases a New “GetEyeWise” Digital Campaign to Bring ...
Bastillepost· 1 日前As May marks Vision Health Month, the Canadian Association of Optometrists (CAO) releases a digital national campaign to ...
New York City pension leader opposes election of Aramco's chief as BlackRock director
Reuters· 1 日前A pension fund for New York City employees urged BlackRock's shareholders to vote against the election of Saudi Aramco's ...
Atlassian launches Rovo, its new AI teammate
TechCrunch· 1 日前During its Team ’24 conference in Las Vegas, Atlassian today launched Rovo, its new AI assistant. Rovo can take data from ...
Real. Trial. Lawyers. Launch New Firm — SCHONBUCH HALLISSY LLP to Open Brentwood Office
Bastillepost· 1 日前The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less ...
How to make your home hurricane resistant, as scientists predict an 'extremely active' ...
CNBC· 1 日前In 2024, the national average cost to upgrade an entire house with hurricane windows runs ...
Facing competition from Spotify, Audible to test using Prime Video data for audiobook ...
TechCrunch· 1 日前Amazon has historically operated audiobook marketplace Audible as a separate entity, unconnected to the retailer’s broader ...
Audible to test using Prime Video data for audiobook recommendations as Spotify competition heats up
TechCrunch· 1 日前Amazon has historically operated audiobook marketplace Audible as a separate entity, unconnected to the retailer’s broader ...
28-year-old with net worth over $500,000: 5 money mistakes to avoid in that 'weird time ...
CNBC· 1 日前People in their 20s don't always have much experience managing their finances, which means ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 1 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...